S6 Insights on”As AI Transforms Drug Development, FDA Is Scrambling to Figure Out Guardrails”

In Today’s News: The FDA grapples with the rapid influx of drug submissions utilizing artificial intelligence, numbering around 300 since 2016. This marked transformation in drug development reflects a future filled with innovative AI-driven solutions, demanding new regulatory guardrails to…




